BEIGENE LTD's ticker is BGNE and the CUSIP is 07725L102. A total of 235 filers reported holding BEIGENE LTD in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,259 | +0.9% | 7 | 0.0% | 0.00% | – |
| Q2 2023 | $1,248 | -35.7% | 7 | -22.2% | 0.00% | – |
| Q1 2023 | $1,940 | -2.0% | 9 | 0.0% | 0.00% | – |
| Q4 2022 | $1,979 | -50.5% | 9 | -67.9% | 0.00% | – |
| Q3 2022 | $4,000 | -20.0% | 28 | -6.7% | 0.00% | – |
| Q2 2022 | $5,000 | +25.0% | 30 | +50.0% | 0.00% | – |
| Q1 2022 | $4,000 | -97.0% | 20 | -95.9% | 0.00% | -100.0% |
| Q4 2021 | $133,000 | -34.5% | 490 | -12.2% | 0.00% | -42.9% |
| Q3 2021 | $203,000 | -6.9% | 558 | -12.1% | 0.01% | -22.2% |
| Q2 2021 | $218,000 | +46.3% | 635 | +48.7% | 0.01% | +28.6% |
| Q1 2021 | $149,000 | +132.8% | 427 | +71.5% | 0.01% | +133.3% |
| Q4 2020 | $64,000 | +68.4% | 249 | +90.1% | 0.00% | +50.0% |
| Q3 2020 | $38,000 | +192.3% | 131 | +92.6% | 0.00% | +100.0% |
| Q2 2020 | $13,000 | +1200.0% | 68 | +750.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 194,838 | $38,098,000 | 49.65% |
| HHLR ADVISORS, LTD. | 5,472,259 | $1,032,068,000 | 21.55% |
| Baker Brothers Advisors | 11,668,897 | $2,200,754,000 | 12.64% |
| Artal Group S.A. | 665,000 | $125,419,000 | 5.25% |
| Boxer Capital, LLC | 500,000 | $94,300,000 | 4.85% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 177,592 | $33,494,000 | 4.64% |
| Old Well Partners, LLC | 32,465 | $6,123,000 | 4.11% |
| E Fund Management (Hong Kong) Co., Ltd. | 27,501 | $5,071,000 | 3.22% |
| Long Corridor Asset Management Ltd | 13,600 | $2,565,000 | 3.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $11,398,000 | 2.57% |